- Citado por SciELO
- Citado por Google
- Similares em SciELO
- Similares em Google
Revista do Instituto de Medicina Tropical de São Paulo
versão impressa ISSN 0036-4665
MUTISO, Joshua M. et al. Safety and skin delayed-type hypersensitivity response in vervet monkeys immunized with Leishmania donovani sonicate antigen delivered with adjuvants. Rev. Inst. Med. trop. S. Paulo [online]. 2012, vol.54, n.1, pp. 37-41. ISSN 0036-4665. http://dx.doi.org/10.1590/S0036-46652012000100007.
In this study, we report on the safety and skin delayed-type hypersensitivity (DTH), responses of the Leishmania donovani whole cell sonicate antigen delivered in conjunction with alum-BCG (AlBCG), Montanide ISA 720 (MISA) or Monophosphoryl lipid A (MPLA) in groups of vervet monkeys. Following three intradermal injections of the inoculums on days 0, 28 and 42, safety and DTH responses were assessed. Preliminary tumor necrosis factor alpha (TNF-α) and interferon gamma (IFN-γ) levels were also measured and these were compared with DTH. Only those animals immunized with alum-BCG reacted adversely to the inoculum by producing ulcerative erythematous skin indurations. Non-parametric analysis of variance followed by a post-test showed significantly higher DTH responses in the MISA+Ag group compared with other immunized groups (p < 0.001). The MPLA+Ag group indicated significantly lower DTH responses to the sonicate antigen compared with the AlBCG+Ag group. There was a significant correlation between the DTH and cytokine responses (p < 0.0001). Based on this study we conclude that Leishmania donovani sonicate antigen containing MISA 720 is safe and is associated with a strong DTH reaction following immunization.
Palavras-chave : Safety; Delayed-type hypersensitivity (DTH); Vervet monkeys; Leishmania donovani sonicate antigen; Adjuvants.